Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade
- RabMAb
- Advanced Validation
- Recombinant
- KO Validated
- What is this?
1
(1 Review)
|
(11 Publications)
Rabbit Recombinant Monoclonal SUZ12 antibody. Suitable for ChIC/CUT&RUN-seq, IP, ChIP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse samples. Cited in 11 publications.
View Alternative Names
CHET9, JJAZ1, KIAA0160, SUZ12, Polycomb protein SUZ12, Chromatin precipitated E2F target 9 protein, Joined to JAZF1 protein, Suppressor of zeste 12 protein homolog, ChET 9 protein
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
Immunofluorescence analysis of MCF-7 cells labeling SUZ12 with ab175187 at a 1/50 dilution.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
Intracellular Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling SUZ12 (red) with purified ab175187 at a 1/2000 dilution (1ug/mL). Cells were fixed with 4% paraformaldehyde and permeabilized with 90% methanol. A goat anti rabbit IgG (Alexa Fluor® 488) (ab150077) was used as the secondary antibody at a 1/2000 dilution. Black - Rabbit monoclonal IgG (Black) (ab172730). Blue (unlabeled control) - Cell without incubation with primary antibody and secondary antibody (Blue).
- ChIP
Unknown
ChIP - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
Chromatin was prepared from HeLa cells according to the Abcam Dual X-ChIP protocol*. Cells were fixed with EGS for 30 minutes, then formaldehyde for 10 minutes.
The ChIP was performed with 25 µg of chromatin, 5 µg of ab175187 (red), and 20 µl of Protein A/G sepharose beads. 5 µg of rabbit normal IgG was added to the beads control (gray). The immunoprecipitated DNA was quantified by real time PCR (Sybr green approach).
Primers and probes are located in the first kb of the transcribed region.
*http : //www.abcam.com/resources?keywords=X%20ChIP%20protocol
- IP
Supplier Data
Immunoprecipitation - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
Western blot analysis on immunoprecipitation pellet from HeLa cell lysate using ab175187 at a 1/10 dilution.
All lanes:
Immunoprecipitation - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (ab175187)
Predicted band size: 83 kDa
false
- IP
Lab
Immunoprecipitation - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
ab175187 (purified) at 1/20 dilution (16 μg/mL) immunoprecipitating SUZ12 in HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 10 μg.
Lane 1 (input) : HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 10 μg
Lane 2 (+) : ab175187 & HeLa whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab175187 in HeLa whole cell lysate
For western blotting, ab175187 at 1/500 dilution (0.636 μg/mL) and veriBlot for IP secondary antibody (HRP) (ab131366) at 1/1000 dilution was used.
Blocking and diluting buffer : 5% NFDM /TBST.
All lanes:
Immunoprecipitation - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (ab175187)
Predicted band size: 83 kDa
false
- ChIP
Unknown
ChIP - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
Chromatin was prepared from F9 cells according to the Abcam X-ChIP protocol. Cells were fixed with formaldehyde for 10 minutes.
The ChIP was performed with 25 µg of chromatin, 5 µg of ab175187 (red), and 20 µl of Protein A/G sepharose beads. 5 µg of rabbit normal IgG was added to the beads control (gray). The immunoprecipitated DNA was quantified by real time PCR (Taqman approach for active and inactive loci).
Primers and probes are located in the first kb of the transcribed region.
- WB
Supplier Data
Western blot - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
All lanes:
Western blot - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (ab175187) at 1/1000 dilution
Lane 1:
SW480 cell lysates at 10 µg
Lane 2:
HeLa cell lysates at 10 µg
Lane 3:
MCF-7 cell lysates at 10 µg
Lane 4:
293T cell lysates at 10 µg
Predicted band size: 83 kDa
false
- WB
Lab
Western blot - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : SUZ12 knockout HAP1 cell lysate (20 μg)
Lane 3 : Caco2 cell lysate (20 μg)
Lane 4 : MCF7 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab175187 observed at 100 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab175187 was shown to specifically react with SUZ12 in wild-type HAP1 cells along with additional cross-reactive bands. No band was observed when SUZ12 knockout samples were used. Wild-type and SUZ12 knockout samples were subjected to SDS-PAGE. ab175187 and ab8245 (loading control to GAPDH) were both 1/1000 and 1/10,000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10,000 dilution for 1hr at room temperature before imaging.
All lanes:
Western blot - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (ab175187)
Predicted band size: 83 kDa
false
- WB
Lab
Western blot - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
Lanes 1 - 2 : Merged signal (red and green). Green - ab175187 observed at 90 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55 kDa.
ab175187 was shown to react with SUZ12 in wild-type HAP1 cells in Western blot with loss of signal observed in SUZ12 knockout sample. Wild-type HAP1 and SUZ12 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab175187 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (ab175187) at 1/1000 dilution
Lane 1:
Wild-type HAP1 cell lysate at 20 µg
Lane 2:
SUZ12 knockout HAP1 cell lysate at 20 µg
Predicted band size: 83 kDa
Observed band size: 90 kDa
false
- WB
Unknown
Western blot - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
Lanes 1- 2 : Merged signal (red and green). Green - ab175187 observed at 100 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab175187 was shown to react with SUZ12 in wild-type HeLa cells in western blot. The band observed in knockout cell line ab264983 (knockout cell lysate ab257721) lane below 100kDa may represent truncated forms and cleaved fragments. This has not been investigated further. Wild-type HeLa and SUZ12 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab175187 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (ab175187) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
SUZ12 knockout HeLa cell lysate at 20 µg
Predicted band size: 83 kDa
Observed band size: 100 kDa
false
- WB
Lab
Western blot - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
Lanes 1- 2 : Merged signal (red and green). Green - ab175187 observed at 100 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab175187 was shown to react with SUZ12 in wild-type HeLa cells in western blot. The band observed in CRISPR/Cas9 edited cell line ab264983 (CRISPR/Cas9 edited cell lysate ab257721) lane below 100kDa may represent truncated forms and cleaved fragments. This has not been investigated further. Wild-type HeLa and SUZ12 CRISPR/Cas9 edited HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab175187 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (ab175187) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
SUZ12 CRISPR/Cas9 edited HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human SUZ12 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-suz12-knockout-hela-cell-line-ab264983'>ab264983</a>)
Predicted band size: 83 kDa
Observed band size: 100 kDa
false
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2 x 10^5 HeLa (Human cervix adenocarcinoma epithelial cell line) cells and 5µg of ab175187 [EPR5234(N)]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade (AB175187)
CUT&RUN was performed using the ChIC/CUT&RUN pAG-MNAse ab285373, 2.5 x 10^5 HeLa cells, and 5μg of ab175187 [EPR5234(N)]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. Additional screenshots of mapped reads can be downloaded here.
Related conjugates and formulations (2)
-
Anti-SUZ12 antibody [EPR5234(N)] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-SUZ12 antibody [EPR5234(N)]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download chicCutRunSequencingBooklet|en
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Cellular & molecular biology letters 30:115 PubMed41053540
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:24858 PubMed40640307
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell proliferation 58:e13756 PubMed39358887
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular reproduction and development 90:758-770 PubMed37548351
2023
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 42:e111473 PubMed36719036
2023
Applications
Unspecified application
Species
Unspecified reactive species
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 33:453-466 PubMed34519833
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 49:4421-4440 PubMed33849069
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 11:1061 PubMed33311453
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 18:1607-1616 PubMed31423228
2019
Applications
Unspecified application
Species
Unspecified reactive species
Genome biology 19:229 PubMed30591072
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com